Global Human Microbiome Market Research Report 2024(Status and Outlook)
Report Overview:
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The Global Human Microbiome Market Size was estimated at USD 476.51 million in 2023 and is projected to reach USD 1548.14 million by 2029, exhibiting a CAGR of 21.70% during the forecast period.
This report provides a deep insight into the global Human Microbiome market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Microbiome Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Microbiome market in any manner.
Global Human Microbiome Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Market Segmentation (by Type)
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Market Segmentation (by Application)
Treatment
Diagnosis
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Microbiome Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The Global Human Microbiome Market Size was estimated at USD 476.51 million in 2023 and is projected to reach USD 1548.14 million by 2029, exhibiting a CAGR of 21.70% during the forecast period.
This report provides a deep insight into the global Human Microbiome market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Microbiome Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Microbiome market in any manner.
Global Human Microbiome Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Market Segmentation (by Type)
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Market Segmentation (by Application)
Treatment
Diagnosis
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Human Microbiome Market
- Overview of the regional outlook of the Human Microbiome Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Microbiome Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Microbiome
1.2 Key Market Segments
1.2.1 Human Microbiome Segment by Type
1.2.2 Human Microbiome Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN MICROBIOME MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Microbiome Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Microbiome Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN MICROBIOME MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Microbiome Sales by Manufacturers (2019-2024)
3.2 Global Human Microbiome Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Microbiome Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Microbiome Sales Sites, Area Served, Product Type
3.6 Human Microbiome Market Competitive Situation and Trends
3.6.1 Human Microbiome Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Microbiome Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN MICROBIOME INDUSTRY CHAIN ANALYSIS
4.1 Human Microbiome Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN MICROBIOME MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN MICROBIOME MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Microbiome Sales Market Share by Type (2019-2024)
6.3 Global Human Microbiome Market Size Market Share by Type (2019-2024)
6.4 Global Human Microbiome Price by Type (2019-2024)
7 HUMAN MICROBIOME MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Microbiome Market Sales by Application (2019-2024)
7.3 Global Human Microbiome Market Size (M USD) by Application (2019-2024)
7.4 Global Human Microbiome Sales Growth Rate by Application (2019-2024)
8 HUMAN MICROBIOME MARKET SEGMENTATION BY REGION
8.1 Global Human Microbiome Sales by Region
8.1.1 Global Human Microbiome Sales by Region
8.1.2 Global Human Microbiome Sales Market Share by Region
8.2 North America
8.2.1 North America Human Microbiome Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Microbiome Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Microbiome Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Microbiome Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Microbiome Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Vedanta
9.1.1 Vedanta Human Microbiome Basic Information
9.1.2 Vedanta Human Microbiome Product Overview
9.1.3 Vedanta Human Microbiome Product Market Performance
9.1.4 Vedanta Business Overview
9.1.5 Vedanta Human Microbiome SWOT Analysis
9.1.6 Vedanta Recent Developments
9.2 Seres Therapeutics
9.2.1 Seres Therapeutics Human Microbiome Basic Information
9.2.2 Seres Therapeutics Human Microbiome Product Overview
9.2.3 Seres Therapeutics Human Microbiome Product Market Performance
9.2.4 Seres Therapeutics Business Overview
9.2.5 Seres Therapeutics Human Microbiome SWOT Analysis
9.2.6 Seres Therapeutics Recent Developments
9.3 Second Genome
9.3.1 Second Genome Human Microbiome Basic Information
9.3.2 Second Genome Human Microbiome Product Overview
9.3.3 Second Genome Human Microbiome Product Market Performance
9.3.4 Second Genome Human Microbiome SWOT Analysis
9.3.5 Second Genome Business Overview
9.3.6 Second Genome Recent Developments
9.4 Rebiotix
9.4.1 Rebiotix Human Microbiome Basic Information
9.4.2 Rebiotix Human Microbiome Product Overview
9.4.3 Rebiotix Human Microbiome Product Market Performance
9.4.4 Rebiotix Business Overview
9.4.5 Rebiotix Recent Developments
9.5 ActoGeniX
9.5.1 ActoGeniX Human Microbiome Basic Information
9.5.2 ActoGeniX Human Microbiome Product Overview
9.5.3 ActoGeniX Human Microbiome Product Market Performance
9.5.4 ActoGeniX Business Overview
9.5.5 ActoGeniX Recent Developments
9.6 Enterome BioScience
9.6.1 Enterome BioScience Human Microbiome Basic Information
9.6.2 Enterome BioScience Human Microbiome Product Overview
9.6.3 Enterome BioScience Human Microbiome Product Market Performance
9.6.4 Enterome BioScience Business Overview
9.6.5 Enterome BioScience Recent Developments
9.7 AvidBiotics
9.7.1 AvidBiotics Human Microbiome Basic Information
9.7.2 AvidBiotics Human Microbiome Product Overview
9.7.3 AvidBiotics Human Microbiome Product Market Performance
9.7.4 AvidBiotics Business Overview
9.7.5 AvidBiotics Recent Developments
9.8 4D Pharma Research Ltd
9.8.1 4D Pharma Research Ltd Human Microbiome Basic Information
9.8.2 4D Pharma Research Ltd Human Microbiome Product Overview
9.8.3 4D Pharma Research Ltd Human Microbiome Product Market Performance
9.8.4 4D Pharma Research Ltd Business Overview
9.8.5 4D Pharma Research Ltd Recent Developments
9.9 Enterologics
9.9.1 Enterologics Human Microbiome Basic Information
9.9.2 Enterologics Human Microbiome Product Overview
9.9.3 Enterologics Human Microbiome Product Market Performance
9.9.4 Enterologics Business Overview
9.9.5 Enterologics Recent Developments
9.10 Metabogen
9.10.1 Metabogen Human Microbiome Basic Information
9.10.2 Metabogen Human Microbiome Product Overview
9.10.3 Metabogen Human Microbiome Product Market Performance
9.10.4 Metabogen Business Overview
9.10.5 Metabogen Recent Developments
9.11 Metabiomics
9.11.1 Metabiomics Human Microbiome Basic Information
9.11.2 Metabiomics Human Microbiome Product Overview
9.11.3 Metabiomics Human Microbiome Product Market Performance
9.11.4 Metabiomics Business Overview
9.11.5 Metabiomics Recent Developments
9.12 Ritter Pharmaceuticals
9.12.1 Ritter Pharmaceuticals Human Microbiome Basic Information
9.12.2 Ritter Pharmaceuticals Human Microbiome Product Overview
9.12.3 Ritter Pharmaceuticals Human Microbiome Product Market Performance
9.12.4 Ritter Pharmaceuticals Business Overview
9.12.5 Ritter Pharmaceuticals Recent Developments
9.13 Osel
9.13.1 Osel Human Microbiome Basic Information
9.13.2 Osel Human Microbiome Product Overview
9.13.3 Osel Human Microbiome Product Market Performance
9.13.4 Osel Business Overview
9.13.5 Osel Recent Developments
9.14 Symberix
9.14.1 Symberix Human Microbiome Basic Information
9.14.2 Symberix Human Microbiome Product Overview
9.14.3 Symberix Human Microbiome Product Market Performance
9.14.4 Symberix Business Overview
9.14.5 Symberix Recent Developments
9.15 Miomics
9.15.1 Miomics Human Microbiome Basic Information
9.15.2 Miomics Human Microbiome Product Overview
9.15.3 Miomics Human Microbiome Product Market Performance
9.15.4 Miomics Business Overview
9.15.5 Miomics Recent Developments
9.16 Symbiotix Biotherapies
9.16.1 Symbiotix Biotherapies Human Microbiome Basic Information
9.16.2 Symbiotix Biotherapies Human Microbiome Product Overview
9.16.3 Symbiotix Biotherapies Human Microbiome Product Market Performance
9.16.4 Symbiotix Biotherapies Business Overview
9.16.5 Symbiotix Biotherapies Recent Developments
9.17 MicroBiome Therapeutics LLC
9.17.1 MicroBiome Therapeutics LLC Human Microbiome Basic Information
9.17.2 MicroBiome Therapeutics LLC Human Microbiome Product Overview
9.17.3 MicroBiome Therapeutics LLC Human Microbiome Product Market Performance
9.17.4 MicroBiome Therapeutics LLC Business Overview
9.17.5 MicroBiome Therapeutics LLC Recent Developments
10 HUMAN MICROBIOME MARKET FORECAST BY REGION
10.1 Global Human Microbiome Market Size Forecast
10.2 Global Human Microbiome Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Microbiome Market Size Forecast by Country
10.2.3 Asia Pacific Human Microbiome Market Size Forecast by Region
10.2.4 South America Human Microbiome Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Microbiome by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Microbiome Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Microbiome by Type (2025-2030)
11.1.2 Global Human Microbiome Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Microbiome by Type (2025-2030)
11.2 Global Human Microbiome Market Forecast by Application (2025-2030)
11.2.1 Global Human Microbiome Sales (K Units) Forecast by Application
11.2.2 Global Human Microbiome Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Microbiome
1.2 Key Market Segments
1.2.1 Human Microbiome Segment by Type
1.2.2 Human Microbiome Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN MICROBIOME MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Microbiome Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Microbiome Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN MICROBIOME MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Microbiome Sales by Manufacturers (2019-2024)
3.2 Global Human Microbiome Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Microbiome Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Microbiome Sales Sites, Area Served, Product Type
3.6 Human Microbiome Market Competitive Situation and Trends
3.6.1 Human Microbiome Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Microbiome Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN MICROBIOME INDUSTRY CHAIN ANALYSIS
4.1 Human Microbiome Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN MICROBIOME MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN MICROBIOME MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Microbiome Sales Market Share by Type (2019-2024)
6.3 Global Human Microbiome Market Size Market Share by Type (2019-2024)
6.4 Global Human Microbiome Price by Type (2019-2024)
7 HUMAN MICROBIOME MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Microbiome Market Sales by Application (2019-2024)
7.3 Global Human Microbiome Market Size (M USD) by Application (2019-2024)
7.4 Global Human Microbiome Sales Growth Rate by Application (2019-2024)
8 HUMAN MICROBIOME MARKET SEGMENTATION BY REGION
8.1 Global Human Microbiome Sales by Region
8.1.1 Global Human Microbiome Sales by Region
8.1.2 Global Human Microbiome Sales Market Share by Region
8.2 North America
8.2.1 North America Human Microbiome Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Microbiome Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Microbiome Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Microbiome Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Microbiome Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Vedanta
9.1.1 Vedanta Human Microbiome Basic Information
9.1.2 Vedanta Human Microbiome Product Overview
9.1.3 Vedanta Human Microbiome Product Market Performance
9.1.4 Vedanta Business Overview
9.1.5 Vedanta Human Microbiome SWOT Analysis
9.1.6 Vedanta Recent Developments
9.2 Seres Therapeutics
9.2.1 Seres Therapeutics Human Microbiome Basic Information
9.2.2 Seres Therapeutics Human Microbiome Product Overview
9.2.3 Seres Therapeutics Human Microbiome Product Market Performance
9.2.4 Seres Therapeutics Business Overview
9.2.5 Seres Therapeutics Human Microbiome SWOT Analysis
9.2.6 Seres Therapeutics Recent Developments
9.3 Second Genome
9.3.1 Second Genome Human Microbiome Basic Information
9.3.2 Second Genome Human Microbiome Product Overview
9.3.3 Second Genome Human Microbiome Product Market Performance
9.3.4 Second Genome Human Microbiome SWOT Analysis
9.3.5 Second Genome Business Overview
9.3.6 Second Genome Recent Developments
9.4 Rebiotix
9.4.1 Rebiotix Human Microbiome Basic Information
9.4.2 Rebiotix Human Microbiome Product Overview
9.4.3 Rebiotix Human Microbiome Product Market Performance
9.4.4 Rebiotix Business Overview
9.4.5 Rebiotix Recent Developments
9.5 ActoGeniX
9.5.1 ActoGeniX Human Microbiome Basic Information
9.5.2 ActoGeniX Human Microbiome Product Overview
9.5.3 ActoGeniX Human Microbiome Product Market Performance
9.5.4 ActoGeniX Business Overview
9.5.5 ActoGeniX Recent Developments
9.6 Enterome BioScience
9.6.1 Enterome BioScience Human Microbiome Basic Information
9.6.2 Enterome BioScience Human Microbiome Product Overview
9.6.3 Enterome BioScience Human Microbiome Product Market Performance
9.6.4 Enterome BioScience Business Overview
9.6.5 Enterome BioScience Recent Developments
9.7 AvidBiotics
9.7.1 AvidBiotics Human Microbiome Basic Information
9.7.2 AvidBiotics Human Microbiome Product Overview
9.7.3 AvidBiotics Human Microbiome Product Market Performance
9.7.4 AvidBiotics Business Overview
9.7.5 AvidBiotics Recent Developments
9.8 4D Pharma Research Ltd
9.8.1 4D Pharma Research Ltd Human Microbiome Basic Information
9.8.2 4D Pharma Research Ltd Human Microbiome Product Overview
9.8.3 4D Pharma Research Ltd Human Microbiome Product Market Performance
9.8.4 4D Pharma Research Ltd Business Overview
9.8.5 4D Pharma Research Ltd Recent Developments
9.9 Enterologics
9.9.1 Enterologics Human Microbiome Basic Information
9.9.2 Enterologics Human Microbiome Product Overview
9.9.3 Enterologics Human Microbiome Product Market Performance
9.9.4 Enterologics Business Overview
9.9.5 Enterologics Recent Developments
9.10 Metabogen
9.10.1 Metabogen Human Microbiome Basic Information
9.10.2 Metabogen Human Microbiome Product Overview
9.10.3 Metabogen Human Microbiome Product Market Performance
9.10.4 Metabogen Business Overview
9.10.5 Metabogen Recent Developments
9.11 Metabiomics
9.11.1 Metabiomics Human Microbiome Basic Information
9.11.2 Metabiomics Human Microbiome Product Overview
9.11.3 Metabiomics Human Microbiome Product Market Performance
9.11.4 Metabiomics Business Overview
9.11.5 Metabiomics Recent Developments
9.12 Ritter Pharmaceuticals
9.12.1 Ritter Pharmaceuticals Human Microbiome Basic Information
9.12.2 Ritter Pharmaceuticals Human Microbiome Product Overview
9.12.3 Ritter Pharmaceuticals Human Microbiome Product Market Performance
9.12.4 Ritter Pharmaceuticals Business Overview
9.12.5 Ritter Pharmaceuticals Recent Developments
9.13 Osel
9.13.1 Osel Human Microbiome Basic Information
9.13.2 Osel Human Microbiome Product Overview
9.13.3 Osel Human Microbiome Product Market Performance
9.13.4 Osel Business Overview
9.13.5 Osel Recent Developments
9.14 Symberix
9.14.1 Symberix Human Microbiome Basic Information
9.14.2 Symberix Human Microbiome Product Overview
9.14.3 Symberix Human Microbiome Product Market Performance
9.14.4 Symberix Business Overview
9.14.5 Symberix Recent Developments
9.15 Miomics
9.15.1 Miomics Human Microbiome Basic Information
9.15.2 Miomics Human Microbiome Product Overview
9.15.3 Miomics Human Microbiome Product Market Performance
9.15.4 Miomics Business Overview
9.15.5 Miomics Recent Developments
9.16 Symbiotix Biotherapies
9.16.1 Symbiotix Biotherapies Human Microbiome Basic Information
9.16.2 Symbiotix Biotherapies Human Microbiome Product Overview
9.16.3 Symbiotix Biotherapies Human Microbiome Product Market Performance
9.16.4 Symbiotix Biotherapies Business Overview
9.16.5 Symbiotix Biotherapies Recent Developments
9.17 MicroBiome Therapeutics LLC
9.17.1 MicroBiome Therapeutics LLC Human Microbiome Basic Information
9.17.2 MicroBiome Therapeutics LLC Human Microbiome Product Overview
9.17.3 MicroBiome Therapeutics LLC Human Microbiome Product Market Performance
9.17.4 MicroBiome Therapeutics LLC Business Overview
9.17.5 MicroBiome Therapeutics LLC Recent Developments
10 HUMAN MICROBIOME MARKET FORECAST BY REGION
10.1 Global Human Microbiome Market Size Forecast
10.2 Global Human Microbiome Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Microbiome Market Size Forecast by Country
10.2.3 Asia Pacific Human Microbiome Market Size Forecast by Region
10.2.4 South America Human Microbiome Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Microbiome by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Microbiome Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Microbiome by Type (2025-2030)
11.1.2 Global Human Microbiome Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Microbiome by Type (2025-2030)
11.2 Global Human Microbiome Market Forecast by Application (2025-2030)
11.2.1 Global Human Microbiome Sales (K Units) Forecast by Application
11.2.2 Global Human Microbiome Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Microbiome Market Size Comparison by Region (M USD)
Table 5. Global Human Microbiome Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Human Microbiome Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Microbiome Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Microbiome Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2022)
Table 10. Global Market Human Microbiome Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Microbiome Sales Sites and Area Served
Table 12. Manufacturers Human Microbiome Product Type
Table 13. Global Human Microbiome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Microbiome
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Microbiome Market Challenges
Table 22. Global Human Microbiome Sales by Type (K Units)
Table 23. Global Human Microbiome Market Size by Type (M USD)
Table 24. Global Human Microbiome Sales (K Units) by Type (2019-2024)
Table 25. Global Human Microbiome Sales Market Share by Type (2019-2024)
Table 26. Global Human Microbiome Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Microbiome Market Size Share by Type (2019-2024)
Table 28. Global Human Microbiome Price (USD/Unit) by Type (2019-2024)
Table 29. Global Human Microbiome Sales (K Units) by Application
Table 30. Global Human Microbiome Market Size by Application
Table 31. Global Human Microbiome Sales by Application (2019-2024) & (K Units)
Table 32. Global Human Microbiome Sales Market Share by Application (2019-2024)
Table 33. Global Human Microbiome Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Microbiome Market Share by Application (2019-2024)
Table 35. Global Human Microbiome Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Microbiome Sales by Region (2019-2024) & (K Units)
Table 37. Global Human Microbiome Sales Market Share by Region (2019-2024)
Table 38. North America Human Microbiome Sales by Country (2019-2024) & (K Units)
Table 39. Europe Human Microbiome Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Human Microbiome Sales by Region (2019-2024) & (K Units)
Table 41. South America Human Microbiome Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Human Microbiome Sales by Region (2019-2024) & (K Units)
Table 43. Vedanta Human Microbiome Basic Information
Table 44. Vedanta Human Microbiome Product Overview
Table 45. Vedanta Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Vedanta Business Overview
Table 47. Vedanta Human Microbiome SWOT Analysis
Table 48. Vedanta Recent Developments
Table 49. Seres Therapeutics Human Microbiome Basic Information
Table 50. Seres Therapeutics Human Microbiome Product Overview
Table 51. Seres Therapeutics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Seres Therapeutics Business Overview
Table 53. Seres Therapeutics Human Microbiome SWOT Analysis
Table 54. Seres Therapeutics Recent Developments
Table 55. Second Genome Human Microbiome Basic Information
Table 56. Second Genome Human Microbiome Product Overview
Table 57. Second Genome Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Second Genome Human Microbiome SWOT Analysis
Table 59. Second Genome Business Overview
Table 60. Second Genome Recent Developments
Table 61. Rebiotix Human Microbiome Basic Information
Table 62. Rebiotix Human Microbiome Product Overview
Table 63. Rebiotix Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Rebiotix Business Overview
Table 65. Rebiotix Recent Developments
Table 66. ActoGeniX Human Microbiome Basic Information
Table 67. ActoGeniX Human Microbiome Product Overview
Table 68. ActoGeniX Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. ActoGeniX Business Overview
Table 70. ActoGeniX Recent Developments
Table 71. Enterome BioScience Human Microbiome Basic Information
Table 72. Enterome BioScience Human Microbiome Product Overview
Table 73. Enterome BioScience Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Enterome BioScience Business Overview
Table 75. Enterome BioScience Recent Developments
Table 76. AvidBiotics Human Microbiome Basic Information
Table 77. AvidBiotics Human Microbiome Product Overview
Table 78. AvidBiotics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. AvidBiotics Business Overview
Table 80. AvidBiotics Recent Developments
Table 81. 4D Pharma Research Ltd Human Microbiome Basic Information
Table 82. 4D Pharma Research Ltd Human Microbiome Product Overview
Table 83. 4D Pharma Research Ltd Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. 4D Pharma Research Ltd Business Overview
Table 85. 4D Pharma Research Ltd Recent Developments
Table 86. Enterologics Human Microbiome Basic Information
Table 87. Enterologics Human Microbiome Product Overview
Table 88. Enterologics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Enterologics Business Overview
Table 90. Enterologics Recent Developments
Table 91. Metabogen Human Microbiome Basic Information
Table 92. Metabogen Human Microbiome Product Overview
Table 93. Metabogen Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Metabogen Business Overview
Table 95. Metabogen Recent Developments
Table 96. Metabiomics Human Microbiome Basic Information
Table 97. Metabiomics Human Microbiome Product Overview
Table 98. Metabiomics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Metabiomics Business Overview
Table 100. Metabiomics Recent Developments
Table 101. Ritter Pharmaceuticals Human Microbiome Basic Information
Table 102. Ritter Pharmaceuticals Human Microbiome Product Overview
Table 103. Ritter Pharmaceuticals Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Ritter Pharmaceuticals Business Overview
Table 105. Ritter Pharmaceuticals Recent Developments
Table 106. Osel Human Microbiome Basic Information
Table 107. Osel Human Microbiome Product Overview
Table 108. Osel Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Osel Business Overview
Table 110. Osel Recent Developments
Table 111. Symberix Human Microbiome Basic Information
Table 112. Symberix Human Microbiome Product Overview
Table 113. Symberix Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Symberix Business Overview
Table 115. Symberix Recent Developments
Table 116. Miomics Human Microbiome Basic Information
Table 117. Miomics Human Microbiome Product Overview
Table 118. Miomics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Miomics Business Overview
Table 120. Miomics Recent Developments
Table 121. Symbiotix Biotherapies Human Microbiome Basic Information
Table 122. Symbiotix Biotherapies Human Microbiome Product Overview
Table 123. Symbiotix Biotherapies Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Symbiotix Biotherapies Business Overview
Table 125. Symbiotix Biotherapies Recent Developments
Table 126. MicroBiome Therapeutics LLC Human Microbiome Basic Information
Table 127. MicroBiome Therapeutics LLC Human Microbiome Product Overview
Table 128. MicroBiome Therapeutics LLC Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. MicroBiome Therapeutics LLC Business Overview
Table 130. MicroBiome Therapeutics LLC Recent Developments
Table 131. Global Human Microbiome Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Human Microbiome Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Human Microbiome Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Human Microbiome Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Human Microbiome Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Human Microbiome Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Human Microbiome Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Human Microbiome Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Human Microbiome Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Human Microbiome Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Human Microbiome Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Human Microbiome Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Human Microbiome Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Human Microbiome Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Human Microbiome Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Human Microbiome Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Human Microbiome Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Microbiome Market Size Comparison by Region (M USD)
Table 5. Global Human Microbiome Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Human Microbiome Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Microbiome Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Microbiome Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2022)
Table 10. Global Market Human Microbiome Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Microbiome Sales Sites and Area Served
Table 12. Manufacturers Human Microbiome Product Type
Table 13. Global Human Microbiome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Microbiome
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Microbiome Market Challenges
Table 22. Global Human Microbiome Sales by Type (K Units)
Table 23. Global Human Microbiome Market Size by Type (M USD)
Table 24. Global Human Microbiome Sales (K Units) by Type (2019-2024)
Table 25. Global Human Microbiome Sales Market Share by Type (2019-2024)
Table 26. Global Human Microbiome Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Microbiome Market Size Share by Type (2019-2024)
Table 28. Global Human Microbiome Price (USD/Unit) by Type (2019-2024)
Table 29. Global Human Microbiome Sales (K Units) by Application
Table 30. Global Human Microbiome Market Size by Application
Table 31. Global Human Microbiome Sales by Application (2019-2024) & (K Units)
Table 32. Global Human Microbiome Sales Market Share by Application (2019-2024)
Table 33. Global Human Microbiome Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Microbiome Market Share by Application (2019-2024)
Table 35. Global Human Microbiome Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Microbiome Sales by Region (2019-2024) & (K Units)
Table 37. Global Human Microbiome Sales Market Share by Region (2019-2024)
Table 38. North America Human Microbiome Sales by Country (2019-2024) & (K Units)
Table 39. Europe Human Microbiome Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Human Microbiome Sales by Region (2019-2024) & (K Units)
Table 41. South America Human Microbiome Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Human Microbiome Sales by Region (2019-2024) & (K Units)
Table 43. Vedanta Human Microbiome Basic Information
Table 44. Vedanta Human Microbiome Product Overview
Table 45. Vedanta Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Vedanta Business Overview
Table 47. Vedanta Human Microbiome SWOT Analysis
Table 48. Vedanta Recent Developments
Table 49. Seres Therapeutics Human Microbiome Basic Information
Table 50. Seres Therapeutics Human Microbiome Product Overview
Table 51. Seres Therapeutics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Seres Therapeutics Business Overview
Table 53. Seres Therapeutics Human Microbiome SWOT Analysis
Table 54. Seres Therapeutics Recent Developments
Table 55. Second Genome Human Microbiome Basic Information
Table 56. Second Genome Human Microbiome Product Overview
Table 57. Second Genome Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Second Genome Human Microbiome SWOT Analysis
Table 59. Second Genome Business Overview
Table 60. Second Genome Recent Developments
Table 61. Rebiotix Human Microbiome Basic Information
Table 62. Rebiotix Human Microbiome Product Overview
Table 63. Rebiotix Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Rebiotix Business Overview
Table 65. Rebiotix Recent Developments
Table 66. ActoGeniX Human Microbiome Basic Information
Table 67. ActoGeniX Human Microbiome Product Overview
Table 68. ActoGeniX Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. ActoGeniX Business Overview
Table 70. ActoGeniX Recent Developments
Table 71. Enterome BioScience Human Microbiome Basic Information
Table 72. Enterome BioScience Human Microbiome Product Overview
Table 73. Enterome BioScience Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Enterome BioScience Business Overview
Table 75. Enterome BioScience Recent Developments
Table 76. AvidBiotics Human Microbiome Basic Information
Table 77. AvidBiotics Human Microbiome Product Overview
Table 78. AvidBiotics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. AvidBiotics Business Overview
Table 80. AvidBiotics Recent Developments
Table 81. 4D Pharma Research Ltd Human Microbiome Basic Information
Table 82. 4D Pharma Research Ltd Human Microbiome Product Overview
Table 83. 4D Pharma Research Ltd Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. 4D Pharma Research Ltd Business Overview
Table 85. 4D Pharma Research Ltd Recent Developments
Table 86. Enterologics Human Microbiome Basic Information
Table 87. Enterologics Human Microbiome Product Overview
Table 88. Enterologics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Enterologics Business Overview
Table 90. Enterologics Recent Developments
Table 91. Metabogen Human Microbiome Basic Information
Table 92. Metabogen Human Microbiome Product Overview
Table 93. Metabogen Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Metabogen Business Overview
Table 95. Metabogen Recent Developments
Table 96. Metabiomics Human Microbiome Basic Information
Table 97. Metabiomics Human Microbiome Product Overview
Table 98. Metabiomics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Metabiomics Business Overview
Table 100. Metabiomics Recent Developments
Table 101. Ritter Pharmaceuticals Human Microbiome Basic Information
Table 102. Ritter Pharmaceuticals Human Microbiome Product Overview
Table 103. Ritter Pharmaceuticals Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Ritter Pharmaceuticals Business Overview
Table 105. Ritter Pharmaceuticals Recent Developments
Table 106. Osel Human Microbiome Basic Information
Table 107. Osel Human Microbiome Product Overview
Table 108. Osel Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Osel Business Overview
Table 110. Osel Recent Developments
Table 111. Symberix Human Microbiome Basic Information
Table 112. Symberix Human Microbiome Product Overview
Table 113. Symberix Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Symberix Business Overview
Table 115. Symberix Recent Developments
Table 116. Miomics Human Microbiome Basic Information
Table 117. Miomics Human Microbiome Product Overview
Table 118. Miomics Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Miomics Business Overview
Table 120. Miomics Recent Developments
Table 121. Symbiotix Biotherapies Human Microbiome Basic Information
Table 122. Symbiotix Biotherapies Human Microbiome Product Overview
Table 123. Symbiotix Biotherapies Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Symbiotix Biotherapies Business Overview
Table 125. Symbiotix Biotherapies Recent Developments
Table 126. MicroBiome Therapeutics LLC Human Microbiome Basic Information
Table 127. MicroBiome Therapeutics LLC Human Microbiome Product Overview
Table 128. MicroBiome Therapeutics LLC Human Microbiome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. MicroBiome Therapeutics LLC Business Overview
Table 130. MicroBiome Therapeutics LLC Recent Developments
Table 131. Global Human Microbiome Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Human Microbiome Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Human Microbiome Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Human Microbiome Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Human Microbiome Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Human Microbiome Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Human Microbiome Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Human Microbiome Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Human Microbiome Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Human Microbiome Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Human Microbiome Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Human Microbiome Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Human Microbiome Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Human Microbiome Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Human Microbiome Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Human Microbiome Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Human Microbiome Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Microbiome
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Microbiome Market Size (M USD), 2019-2030
Figure 5. Global Human Microbiome Market Size (M USD) (2019-2030)
Figure 6. Global Human Microbiome Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Microbiome Market Size by Country (M USD)
Figure 11. Human Microbiome Sales Share by Manufacturers in 2023
Figure 12. Global Human Microbiome Revenue Share by Manufacturers in 2023
Figure 13. Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Microbiome Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Microbiome Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Microbiome Market Share by Type
Figure 18. Sales Market Share of Human Microbiome by Type (2019-2024)
Figure 19. Sales Market Share of Human Microbiome by Type in 2023
Figure 20. Market Size Share of Human Microbiome by Type (2019-2024)
Figure 21. Market Size Market Share of Human Microbiome by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Microbiome Market Share by Application
Figure 24. Global Human Microbiome Sales Market Share by Application (2019-2024)
Figure 25. Global Human Microbiome Sales Market Share by Application in 2023
Figure 26. Global Human Microbiome Market Share by Application (2019-2024)
Figure 27. Global Human Microbiome Market Share by Application in 2023
Figure 28. Global Human Microbiome Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Microbiome Sales Market Share by Region (2019-2024)
Figure 30. North America Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Human Microbiome Sales Market Share by Country in 2023
Figure 32. U.S. Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Human Microbiome Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Human Microbiome Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Human Microbiome Sales Market Share by Country in 2023
Figure 37. Germany Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Human Microbiome Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Human Microbiome Sales Market Share by Region in 2023
Figure 44. China Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Human Microbiome Sales and Growth Rate (K Units)
Figure 50. South America Human Microbiome Sales Market Share by Country in 2023
Figure 51. Brazil Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Human Microbiome Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Human Microbiome Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Human Microbiome Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Human Microbiome Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Microbiome Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Microbiome Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Microbiome Sales Forecast by Application (2025-2030)
Figure 66. Global Human Microbiome Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Human Microbiome
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Microbiome Market Size (M USD), 2019-2030
Figure 5. Global Human Microbiome Market Size (M USD) (2019-2030)
Figure 6. Global Human Microbiome Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Microbiome Market Size by Country (M USD)
Figure 11. Human Microbiome Sales Share by Manufacturers in 2023
Figure 12. Global Human Microbiome Revenue Share by Manufacturers in 2023
Figure 13. Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Microbiome Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Microbiome Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Microbiome Market Share by Type
Figure 18. Sales Market Share of Human Microbiome by Type (2019-2024)
Figure 19. Sales Market Share of Human Microbiome by Type in 2023
Figure 20. Market Size Share of Human Microbiome by Type (2019-2024)
Figure 21. Market Size Market Share of Human Microbiome by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Microbiome Market Share by Application
Figure 24. Global Human Microbiome Sales Market Share by Application (2019-2024)
Figure 25. Global Human Microbiome Sales Market Share by Application in 2023
Figure 26. Global Human Microbiome Market Share by Application (2019-2024)
Figure 27. Global Human Microbiome Market Share by Application in 2023
Figure 28. Global Human Microbiome Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Microbiome Sales Market Share by Region (2019-2024)
Figure 30. North America Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Human Microbiome Sales Market Share by Country in 2023
Figure 32. U.S. Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Human Microbiome Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Human Microbiome Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Human Microbiome Sales Market Share by Country in 2023
Figure 37. Germany Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Human Microbiome Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Human Microbiome Sales Market Share by Region in 2023
Figure 44. China Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Human Microbiome Sales and Growth Rate (K Units)
Figure 50. South America Human Microbiome Sales Market Share by Country in 2023
Figure 51. Brazil Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Human Microbiome Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Human Microbiome Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Human Microbiome Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Human Microbiome Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Human Microbiome Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Microbiome Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Microbiome Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Microbiome Sales Forecast by Application (2025-2030)
Figure 66. Global Human Microbiome Market Share Forecast by Application (2025-2030)
